Condition
Peptides
Total Trials
5
Recruiting
2
Active
3
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 5 trials
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
5Total
Not Applicable (4)
P 1 (1)
Trial Status
Recruiting2
Not Yet Recruiting2
Active Not Recruiting1
Clinical Trials (5)
Showing 5 of 5 trials
NCT07528469Not ApplicableActive Not Recruiting
The Effects of PeptiStrong and Whey on Muscle Function In Older Adults
NCT07451769Not ApplicableRecruiting
Selective Activation of the Adrenomedullin Receptors in Migraine
NCT07583654Phase 1Recruiting
Safety, Tolerability, and Preliminary Antitumor Activity of Cationic Peptide-IL22BP mRNA in Advanced Solid Tumors
NCT07340775Not ApplicableNot Yet Recruiting
Hypersensitivity to Amylin in Post-Traumatic Headache
NCT07340788Not ApplicableNot Yet Recruiting
Amylin-Induced Migraine Attacks Without Aura
Showing all 5 trials